Skip to content

Auditory Rehabilitation and Cognition in Alzheimer Patients

Auditory Rehabilitation With Hearing Aids and Cognition in Alzheimer Patients

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03002142
Acronym
RACO-MA
Enrollment
9
Registered
2016-12-23
Start date
2017-03-31
Completion date
2020-05-03
Last updated
2021-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease, Hearing Loss

Keywords

Alzheimer, Hearing loss, Cognition, Quality of life, Hearing aids

Brief summary

Alzheimer disease is a neurodegenerative disease. Recent studies suggest that subjects with hearing loss are more likely to develop Alzheimer's disease. Hearing loss can be consecutive to presbycusis and/or to central auditory dysfunction. Standard audiometric measures with pure tone and speech intelligibility allow the diagnosis of presbycusis. However, to demonstrate central auditory dysfunction, specific audiometric tests as noisy and/or dichotic tests, are needed. Actually, no consensus exists to investigate hearing loss in people with Alzheimer's disease; therefore hearing loss may be an early manifestation of Alzheimer's disease. Until now, investigations and clinical procedure related to the diagnosis of Alzheimer's disease ignored the hearing ability of the patient. However, the major part of care management and investigations implies the patient's communication ability with caregivers. Hearing loss may be one of the most unrecognized deficit in subjects with Alzheimer's disease. Auditory rehabilitation with hearing aids could benefit to the patient to decrease cognitive decline but this management must be investigate during longitudinal studies in order to demonstrate their efficiency and need to be compared with a placebo.

Interventions

DEVICEHearing aids

Phonak Audéo B-R (Target V 5.0)

DEVICEPlacebo

Phonak Audéo B-R (Target V 5.0) without amplification

Sponsors

University Hospital, Tours
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Alzheimer patient * Mini Mental state examination= 15-25 or mild cognitive impairment * Over 65 yo * Sensorineural hearing loss with pure tone average over 30 dB * Language: French * Able to sign the consent * Affiliated to the French social security

Exclusion criteria

* Conductive hearing loss * Retrocochlear hearing loss * History of neurological disorders with consequences in hearing loss (vascular accident; brain surgery, cerebral tumors, head trauma with loss consciousness) * patient included in another study * French no spoken * chronic used of drugs or alcohol

Design outcomes

Primary

MeasureTime frameDescription
Changing score in Cognitive functions measured with Alzheimer's Disease Assessment Scale-cognitive scaleChange before and one year after the fitting with deviceFrench scale validated by the french society of geriatry

Secondary

MeasureTime frameDescription
air and bone auditory thresholds (dB HL) measured at 500, 1000, 2000, 3000 and 4000 HzFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceTonal audiometry
Speech recognition threshold (dB HL) measured by speech audiometryFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceSpeech audiometry
Speech Discrimination Test (%) measured by speech audiometryFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceSpeech audiometry
Dichotic test measured with audiometryFrom 1 to 90 days prior the fitting with deviceSpeech audiometry
Amplification with hearing aids or placebo devices measured by tonal and speech audiometry (dB HL)6 months after the fitting with device, 12 months after the fitting with deviceAudiometry
Devices tolerance measured with number of hours per day with hearing aids6 months after the fitting with device, 12 months after the fitting with deviceAudiometry
Objective auditory thresholds measured with auditory brainstem responses (ms)6 months after the fitting with device, 12 months after the fitting with devicein case of uncooperative patients or to confirm tonal audiometry
Objective auditory thresholds measured by Auditory steady state responses (in dB eHL)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with devicein case of uncooperative patients or to confirm tonal audiometry
Mini Mental State Examination (30 items, total score from 0-30)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Hearing Handicap Inventory for Elderly measured by questionnaire (10 items, total score from 0-40)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Hearing loss impact scale in adults measured by 2 questionnaire (Abbreviated Profile of Hearing Aid Benefit, 24 items) and Impact of hearing loss in adults (20 items, total score from 0-200)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Quality of life-Alzheimer disease scale measured by questionnaire (total score from 13-52)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Assessing caregiver burden measured by Zarit scale (22 items, total score from 0-88)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Depression in the elderly measured by Geriatric depression scale (30 items, total score from 0-30)From 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Executive functions measured by trail making testFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Working memory and processing speed measured by Wechsler Adult Intelligence ScaleFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Speech comprehension measured by Beauregard testsFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version
Hearing aids tolerance measured by Glagow hearing-aid benefit questionnaireFrom 1 to 90 days prior the fitting with device, 6 months after the fitting with device, 12 months after the fitting with deviceFrench validated version

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026